GFRAL and obesity due to melanocortin 4 receptor deficiency: Animal studies demonstrate that MT1-MMP knockout restores GFRAL expression, attenuating weight gain and food intake in obese mice, suggesting this pathway as a potential therapeutic target for obesity (Chow et al., 2022).